174 related articles for article (PubMed ID: 22886470)
1. Imported case of visceral leishmaniasis presenting as pancytopenia in a Norwegian patient treated with methotrexate and etanercept for psoriasis arthritis.
Besada E; Njålla RJ; Nossent JC
Rheumatol Int; 2013 Oct; 33(10):2687-9. PubMed ID: 22886470
[TBL] [Abstract][Full Text] [Related]
2. Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
Venizelos I; Tatsiou Z; Papathomas TG; Orazi A
Int J Infect Dis; 2009 Jul; 13(4):e169-72. PubMed ID: 19026580
[TBL] [Abstract][Full Text] [Related]
3. Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study.
Atzeni F; Boccassini L; Antivalle M; Salaffi F; Sarzi-Puttini P
Ann Rheum Dis; 2011 Apr; 70(4):712-4. PubMed ID: 20810394
[No Abstract] [Full Text] [Related]
4. Marked hypertriglyceridemia upon treatment with etanercept.
Haroon M; Devlin J
Joint Bone Spine; 2009 Oct; 76(5):570-1. PubMed ID: 19303341
[No Abstract] [Full Text] [Related]
5. Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema.
Umegaki N; Kira M; Horiuchi T; Itoi S; Tani M; Yokomi A; Tanemura A; Miyahara H; Hatanaka M; Kitamura H; Kitano E; Katayama I
Mod Rheumatol; 2012 Nov; 22(6):928-30. PubMed ID: 22310967
[TBL] [Abstract][Full Text] [Related]
6. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
Iyer S; Yamauchi P; Lowe NJ
Br J Dermatol; 2002 Jan; 146(1):118-21. PubMed ID: 11841377
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
[No Abstract] [Full Text] [Related]
8. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.
Mease PJ
Ann Rheum Dis; 2002 Apr; 61(4):298-304. PubMed ID: 11874829
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of etanercept in lymphedema associated with psoriatic arthritis.
Lekpa FK; Economu-Dubosc A; Fevre C; Claudepierre P; Chevalier X
J Rheumatol; 2009 Jan; 36(1):207-8. PubMed ID: 19208540
[No Abstract] [Full Text] [Related]
10. Successful use of etanercept in acquired angioedema in a patient with psoriatic arthritis.
Rottem M; Mader R
J Rheumatol; 2010 Jan; 37(1):209. PubMed ID: 20040647
[No Abstract] [Full Text] [Related]
11. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
Culy CR; Keating GM
Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
[TBL] [Abstract][Full Text] [Related]
12. Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate.
Reina D; Cerdà D; Güell E; Martínez Montauti J; Pineda A; Corominas H
Reumatol Clin; 2017; 13(6):354-356. PubMed ID: 27523470
[TBL] [Abstract][Full Text] [Related]
13. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis in a psoriatic arthritis patient treated with methotrexate.
Hadjipetrou A; Anyfantakis D; Gkogkou A; Palla K; Lagoudaki E; Milonaki T; Kastanakis S
Infez Med; 2014 Sep; 22(3):230-5. PubMed ID: 25269966
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis and management of psoriatic arthritis in a professional football player presenting with a knee effusion: a case report.
Brophy RH; MacKenzie CR; Gamradt SC; Barnes RP; Rodeo SA; Warren RF
Clin J Sport Med; 2008 Jul; 18(4):369-71. PubMed ID: 18614892
[No Abstract] [Full Text] [Related]
16. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B
J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349
[TBL] [Abstract][Full Text] [Related]
17. From wheels to feet: a dramatic response of severe chronic psoriatic arthritis to etanercept.
ElKayam O; Yaron M; Caspi D
Ann Rheum Dis; 2000 Oct; 59(10):839. PubMed ID: 11203155
[No Abstract] [Full Text] [Related]
18. Psoriatic arthritis: a guide for dermatology nurses.
Gottlieb AB
Dermatol Nurs; 2003 Apr; 15(2):107-10, 113-8; quiz 119. PubMed ID: 12751345
[TBL] [Abstract][Full Text] [Related]
19. Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years.
Yazici Y; Erkan D; Lockshin MD
Clin Exp Rheumatol; 2002; 20(1):115. PubMed ID: 11892697
[No Abstract] [Full Text] [Related]
20. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
Spadaro A; Ceccarelli F; Scrivo R; Valesini G
Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
[No Abstract] [Full Text] [Related]
[Next] [New Search]
